Tevogen Bio Holdings Stock Probability of Future Stock Price Finishing Under 0.09

TVGN Stock   1.42  0.06  4.41%   
Tevogen Bio's future price is the expected price of Tevogen Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Tevogen Bio Holdings performance during a given time horizon utilizing its historical volatility. Check out Tevogen Bio Backtesting, Tevogen Bio Valuation, Tevogen Bio Correlation, Tevogen Bio Hype Analysis, Tevogen Bio Volatility, Tevogen Bio History as well as Tevogen Bio Performance.
  
As of the 21st of November 2024, Price Earnings To Growth Ratio is likely to grow to 283.79, though Price Earnings Ratio is likely to grow to (26 K). Please specify Tevogen Bio's target price for which you would like Tevogen Bio odds to be computed.

Tevogen Bio Target Price Odds to finish below 0.09

The tendency of Tevogen Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to  0.09  or more in 90 days
 1.42 90 days 0.09 
about 11.58
Based on a normal probability distribution, the odds of Tevogen Bio to drop to  0.09  or more in 90 days from now is about 11.58 (This Tevogen Bio Holdings probability density function shows the probability of Tevogen Stock to fall within a particular range of prices over 90 days) . Probability of Tevogen Bio Holdings price to stay between  0.09  and its current price of 1.42 at the end of the 90-day period is about 58.66 .
Given the investment horizon of 90 days Tevogen Bio Holdings has a beta of -3.18. This usually implies as returns on its benchmark rise, returns on holding Tevogen Bio Holdings are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Tevogen Bio is expected to outperform its benchmark. In addition to that Tevogen Bio Holdings has an alpha of 3.5947, implying that it can generate a 3.59 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Tevogen Bio Price Density   
       Price  

Predictive Modules for Tevogen Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Tevogen Bio Holdings. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.071.4228.54
Details
Intrinsic
Valuation
LowRealHigh
0.081.5428.66
Details
Naive
Forecast
LowNextHigh
0.031.4428.56
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.771.882.99
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Tevogen Bio. Your research has to be compared to or analyzed against Tevogen Bio's peers to derive any actionable benefits. When done correctly, Tevogen Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Tevogen Bio Holdings.

Tevogen Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Tevogen Bio is not an exception. The market had few large corrections towards the Tevogen Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Tevogen Bio Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Tevogen Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
3.59
β
Beta against Dow Jones-3.18
σ
Overall volatility
0.77
Ir
Information ratio 0.12

Tevogen Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tevogen Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tevogen Bio Holdings can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Tevogen Bio Holdings is way too risky over 90 days horizon
Tevogen Bio Holdings may become a speculative penny stock
Tevogen Bio Holdings appears to be risky and price may revert if volatility continues
Tevogen Bio Holdings was previously known as Semper Paratus Acquisition and was traded on NASDAQ Exchange under the symbol LGST.
Net Loss for the year was (67.33 K) with profit before overhead, payroll, taxes, and interest of 0.
Tevogen Bio generates negative cash flow from operations
About 97.0% of the company outstanding shares are owned by corporate insiders
Latest headline from gurufocus.com: Tevogen Bio Reports Third Quarter 2024 Financial Results Highlights Significantly Improved ...

Tevogen Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tevogen Stock often depends not only on the future outlook of the current and potential Tevogen Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tevogen Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding165.4 M
Cash And Short Term Investments8835.00

Tevogen Bio Technical Analysis

Tevogen Bio's future price can be derived by breaking down and analyzing its technical indicators over time. Tevogen Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tevogen Bio Holdings. In general, you should focus on analyzing Tevogen Stock price patterns and their correlations with different microeconomic environments and drivers.

Tevogen Bio Predictive Forecast Models

Tevogen Bio's time-series forecasting models is one of many Tevogen Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tevogen Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about Tevogen Bio Holdings

Checking the ongoing alerts about Tevogen Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tevogen Bio Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Tevogen Bio Holdings is way too risky over 90 days horizon
Tevogen Bio Holdings may become a speculative penny stock
Tevogen Bio Holdings appears to be risky and price may revert if volatility continues
Tevogen Bio Holdings was previously known as Semper Paratus Acquisition and was traded on NASDAQ Exchange under the symbol LGST.
Net Loss for the year was (67.33 K) with profit before overhead, payroll, taxes, and interest of 0.
Tevogen Bio generates negative cash flow from operations
About 97.0% of the company outstanding shares are owned by corporate insiders
Latest headline from gurufocus.com: Tevogen Bio Reports Third Quarter 2024 Financial Results Highlights Significantly Improved ...
When determining whether Tevogen Bio Holdings is a strong investment it is important to analyze Tevogen Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Tevogen Bio's future performance. For an informed investment choice regarding Tevogen Stock, refer to the following important reports:
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tevogen Bio. If investors know Tevogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tevogen Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Return On Assets
(0.83)
The market value of Tevogen Bio Holdings is measured differently than its book value, which is the value of Tevogen that is recorded on the company's balance sheet. Investors also form their own opinion of Tevogen Bio's value that differs from its market value or its book value, called intrinsic value, which is Tevogen Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tevogen Bio's market value can be influenced by many factors that don't directly affect Tevogen Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tevogen Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tevogen Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tevogen Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.